CY1120085T1 - Παραγοντας προς χρηση στην περιπτωση δυσανεξιας στην φρουκτοζη - Google Patents

Παραγοντας προς χρηση στην περιπτωση δυσανεξιας στην φρουκτοζη

Info

Publication number
CY1120085T1
CY1120085T1 CY20181100130T CY181100130T CY1120085T1 CY 1120085 T1 CY1120085 T1 CY 1120085T1 CY 20181100130 T CY20181100130 T CY 20181100130T CY 181100130 T CY181100130 T CY 181100130T CY 1120085 T1 CY1120085 T1 CY 1120085T1
Authority
CY
Cyprus
Prior art keywords
fructose
fruitsous
tolerance
factor
case
Prior art date
Application number
CY20181100130T
Other languages
English (en)
Inventor
Daniel Henry Wyrobnik
Isaak Harry Wyrobnik
Original Assignee
Vitacare Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39628203&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1120085(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitacare Gmbh & Co. Kg filed Critical Vitacare Gmbh & Co. Kg
Publication of CY1120085T1 publication Critical patent/CY1120085T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52Isomerases (5)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/99Oxidoreductases acting on the CH-OH group of donors (1.1) with other acceptors (1.1.99)
    • C12Y101/99011Fructose 5-dehydrogenase (1.1.99.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102Alpha-glucosidase (3.2.1.20)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01026Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/01Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01005Xylose isomerase (5.3.1.5)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Η εφεύρεση παρέχει την χρήση ενός παράγοντα που διαθέτει ισομεράση γλυκόζης για (α) τη μείωση της βιολογικής διαθεσιμότητας της φρουκτόζης στο σώμα ενός ανθρώπου ή ζώου ή για (β) τη μείωση της ποσότητας της φρουκτόζης στο σώμα ενός ανθρώπου ή ζώου ή στα εντερικά βακτηρίδια που έχουν αποικίες εκεί μετά την κατάποση μιας τροφής ή ουσίας που περιέχει φρουκτόζη εξαιρώντας την χρήση ενός παράγοντα που περιέχει 5-D-φρουκτόζη αφυδρογονάση.
CY20181100130T 2007-02-20 2018-02-02 Παραγοντας προς χρηση στην περιπτωση δυσανεξιας στην φρουκτοζη CY1120085T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007008664.6A DE102007008664B4 (de) 2007-02-20 2007-02-20 Mittel zur Anwendung bei Fructoseintoleranz
EP08707777A EP2124640B1 (en) 2007-02-20 2008-02-20 Glucose isomerase for use in the treatment of fructose intolerance

Publications (1)

Publication Number Publication Date
CY1120085T1 true CY1120085T1 (el) 2018-12-12

Family

ID=39628203

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100130T CY1120085T1 (el) 2007-02-20 2018-02-02 Παραγοντας προς χρηση στην περιπτωση δυσανεξιας στην φρουκτοζη

Country Status (17)

Country Link
US (10) US8460911B2 (el)
EP (5) EP3456342B1 (el)
AT (1) ATE485832T1 (el)
CA (3) CA2984999A1 (el)
CY (1) CY1120085T1 (el)
DE (2) DE102007008664B4 (el)
DK (3) DK2124640T3 (el)
ES (4) ES2356357T3 (el)
HR (2) HRP20100733T1 (el)
HU (2) HUE041311T2 (el)
IL (1) IL200517A (el)
LT (1) LT2289352T (el)
PL (4) PL3456342T3 (el)
PT (3) PT3295954T (el)
RS (1) RS51896B (el)
SI (2) SI2124640T1 (el)
WO (1) WO2008101672A2 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007059955A2 (en) * 2005-11-23 2007-05-31 Pro Natura Gesellschaft für gesunde Ernährung mbH Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
SI2340035T1 (sl) 2008-09-04 2014-12-31 Sciotec Diagnostic Technologies Gmbh Zdravljenje melabsorbcije fruktoze
GB201417386D0 (en) 2014-10-01 2014-11-12 Nofima As Sugar-depleted fruit or vegetable juice product, method of producing the same and use thereof to maintain health and treat and to prevent medical ailments
FI127298B (en) 2016-06-23 2018-03-15 Fazer Ab Oy Karl An enzyme with fructan hydrolase activity
US11690392B2 (en) 2018-04-18 2023-07-04 Baylor College Of Medicine Development of amyloglucosidase as a medicinal food or dietary supplement
WO2020168306A1 (en) * 2019-02-14 2020-08-20 Gutsybio Inc. Live biotherapeutics for the treatment of carbohydrate disorders

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083A (en) * 1849-02-06 Cooking-stove
GB1455993A (en) * 1973-01-12 1976-11-17 Novo Industri As Glucose isomerase
US4396602A (en) * 1981-09-22 1983-08-02 Asahi Kasei Kogyo Kabushiki Kaisha Blood glucose level lowering agents
SE8505783D0 (sv) 1985-12-06 1985-12-06 Rolf Bergkvist Forfarande for framstellning av livsmedelsprodukter och dessas anvendning
US5436003A (en) * 1994-02-10 1995-07-25 Triarco Industries, Inc. Method of alleviating gastrointestinal distress with a composition containing beta-fructofuransidase, cellulase and hemi-cellulase
ATE400181T1 (de) * 1998-05-13 2008-07-15 Novozymes Inc Verfahren zur verwendung von cellobiosedehydrogenase beim backen
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
JP2000125883A (ja) * 1998-10-21 2000-05-09 Internatl Reagents Corp フルクトキナーゼ及びその遺伝子
WO2000027215A1 (en) 1998-11-05 2000-05-18 Novozymes A/S Methods for using a glucose isomerase in baking
JP4812167B2 (ja) 1999-02-12 2011-11-09 モレキュラー インサイト ファーマスーティカルズ インコーポレイテッド 薬物輸送用マトリックス、ならびにその作成方法および使用方法
ATE283697T1 (de) * 2000-03-01 2004-12-15 Nestle Sa Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort
US6646394B2 (en) * 2001-07-09 2003-11-11 Nissan Motor Co., Ltd. Control device for plurality of rotating electrical machines
US20030113310A1 (en) * 2001-12-17 2003-06-19 Van Laere Katrien Maria Jozefa Method for the treatment of obesity, overweight and fluctuations in blood insuline and/or glucose levels
US7067124B2 (en) 2003-03-28 2006-06-27 National Enzyme Company Protease composition and method for treating a digestive disorder
DE102006013624B4 (de) 2005-11-23 2012-03-15 Pro Natura Gesellschaft für gesunde Ernährung mbH Mittel zur Anwendung bei Fructoseintoleranz
AU2006314188B2 (en) * 2005-11-16 2014-01-16 Pro Natura Gesellschaft Fur Gesunde Ernahrung Mbh Agent for use in the case of fructose intolerance
US20090214620A1 (en) 2005-11-23 2009-08-27 Pro Natura Gesellschaft Fuer Gesunde Ernaehrung Mb Agent for use in the case of disorders of blood sugar metabolism, including diabetes
WO2007059956A1 (en) * 2005-11-23 2007-05-31 Pro Natura Gesellschaft für gesunde Ernährung mbH Agent for use in the case of disorders of blood sugar metabolism, including diabetes
WO2007059955A2 (en) * 2005-11-23 2007-05-31 Pro Natura Gesellschaft für gesunde Ernährung mbH Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
US20090060656A1 (en) 2007-08-28 2009-03-05 Allied Tube & Conduit Corporation Paver edging device and method

Also Published As

Publication number Publication date
HRP20180219T1 (hr) 2018-04-06
US10842854B2 (en) 2020-11-24
US8460911B2 (en) 2013-06-11
US20130302411A1 (en) 2013-11-14
SI2124640T1 (sl) 2011-03-31
PL3456342T3 (pl) 2020-06-15
SI2289352T1 (en) 2018-03-30
CA2716421A1 (en) 2008-08-28
DK2289352T3 (en) 2018-02-12
ES2356357T3 (es) 2011-04-07
EP2289352A2 (en) 2011-03-02
EP3295954B1 (en) 2018-09-12
US20190282678A1 (en) 2019-09-19
EP2124640A2 (en) 2009-12-02
US11147861B2 (en) 2021-10-19
ATE485832T1 (de) 2010-11-15
US9155786B2 (en) 2015-10-13
EP3693005A1 (en) 2020-08-12
DK2124640T3 (da) 2011-01-31
DE602008003199D1 (de) 2010-12-09
EP2289352A3 (en) 2011-05-25
PT3295954T (pt) 2018-12-17
ES2783989T3 (es) 2020-09-21
PL2289352T3 (pl) 2018-04-30
EP2289352B1 (en) 2017-11-29
HRP20100733T1 (hr) 2011-02-28
WO2008101672A3 (en) 2009-06-18
IL200517A0 (en) 2010-04-29
HUE041311T2 (hu) 2019-05-28
US9119860B2 (en) 2015-09-01
EP3456342A1 (en) 2019-03-20
ES2658123T3 (es) 2018-03-08
HUE10010195T2 (hu) 2018-07-30
PT2124640E (pt) 2011-01-13
RS51896B (en) 2012-02-29
EP2124640B1 (en) 2010-10-27
CA2890721A1 (en) 2008-08-28
CA2890721C (en) 2018-01-09
ES2700675T3 (es) 2019-02-18
US11826406B2 (en) 2023-11-28
US20090311232A1 (en) 2009-12-17
DK3295954T3 (da) 2019-01-02
US20130202696A1 (en) 2013-08-08
US9289474B2 (en) 2016-03-22
US20160243207A1 (en) 2016-08-25
US20170319668A1 (en) 2017-11-09
US20220072111A1 (en) 2022-03-10
US20130202695A1 (en) 2013-08-08
DE102007008664A1 (de) 2008-08-21
US20180169197A1 (en) 2018-06-21
DE102007008664B4 (de) 2021-07-29
PL3295954T3 (pl) 2019-02-28
IL200517A (en) 2016-06-30
EP3456342B1 (en) 2020-01-22
LT2289352T (lt) 2018-02-26
PL2124640T3 (pl) 2011-04-29
US20130202694A1 (en) 2013-08-08
WO2008101672A2 (en) 2008-08-28
EP3295954A1 (en) 2018-03-21
CA2716421C (en) 2015-07-21
CA2984999A1 (en) 2008-08-28
PT2289352T (pt) 2018-03-09

Similar Documents

Publication Publication Date Title
CY1120085T1 (el) Παραγοντας προς χρηση στην περιπτωση δυσανεξιας στην φρουκτοζη
CY1118984T1 (el) Παρασκευη ενεργων, ακρως φωσφορυλιωμενων, ανθρωπινων λυσοσωμικων ενζυμων σουλφατασης και χρησεις αυτων
CY1119940T1 (el) Παραγοντας για χρηση στην περιπτωση δυσανεξιας στη φρουκτοζη
CY1120690T1 (el) Κρυσταλλικη μορφη βενζυλοβενζολικου αναστολεα τουsglt2
CY1118934T1 (el) Παρασκευη ενεργης ακρως φωσφορυλιωμενης ανθρωπινης ν-ακετυλογαλακτοζαμινης-6-σουλφατασης και χρησεις αυτης
CO6680687A2 (es) Inmunoglobinas con dominio variable dual capaces de unirse a il 1 beta e il-17, composiciones farmaceúticas y conjugados de proteína de unión de las mismas
EA201000953A1 (ru) Медицинский электрод, пучок электродов и массив из пучков электродов
CR11837A (es) Inmunoglobulinas con dominio variable dual y usos de la misma
DOP2014000084A (es) Inmunoligantes biespecificos dirigidos contra tnf e il-17
CR20120154A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
BR112012023540A2 (pt) um alojamento de um dispositivo eletrônico portátil
MA32876B1 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
NI201200038A (es) Conjugados de niacina y ácidos grasos y sus usos
UY32603A (es) Inmunoglobulina con dominio variable dual y usos de la misma
EA201290078A1 (ru) Гетероциклические соединения для ингибирования pask
CL2011000099A1 (es) Uso de una beta-defensina humana en la manufactura de un medicamento que sirve para el tratamiento de una enfermedad intestinal inflamatoria.
CY1117000T1 (el) Ενζυματικη αντικαρκινικη θεραπεια
GB201010246D0 (en) Stent-Graft
BR112018012070A2 (pt) método para a produção de tecidos/ órgãos utilizando células sanguíneas
EA200900259A1 (ru) Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
FR2867784B1 (fr) Aptameres selectionnes a partir de cellules vivantes tumorales et leurs applications
EA201390220A1 (ru) Высоко биосовместимые композиции хитозана/солей глюкозамина с двусторонним термогелеобразованием
MX2011012114A (es) Solucion farmaceutica bebible de telmisartan.
ES2570386T3 (es) Procedimiento de lucha biológica contra Pseusomonas
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação